CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- FinancialsAltman Z-Score 6.32: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.62%Below 5Y avg (2.06%)
Annual Rate
CNY 0.25Paid unknown
Payout Ratio
96.2%High
Payback Period
60.9 yr
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
2.61BCNY389.52M · vs all stocks (USD)
Trailing P/E
59.50xvs Medical Instruments & Supplies peers
Revenue (TTM)
466.34MCNY69.61M · vs all stocks (USD)
Profit Margin
9.12%vs Medical Instruments & Supplies peers
Beta
0.6920xvs all stocks
52-Week Change
-19.27%vs all stocks
Forward Annual Dividend Yield
1.62%vs all stocks
Market Capitalization
2.61BCNY389.52M · vs all stocks (USD)
Enterprise Value
2.31BCNY344.49M · vs all stocks (USD)
Trailing P/E
59.50xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
5.45xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.23xvs Medical Instruments & Supplies peers
Enterprise to Revenue
4.95xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
46.72xvs Medical Instruments & Supplies peers
Gross Margin
38.97%vs Medical Instruments & Supplies peers
Profit Margin
9.12%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
0.57%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.56%vs Medical Instruments & Supplies peers
Revenue (TTM)
466.34MCNY69.61M · vs all stocks (USD)
Revenue per Share (TTM)
2.77CNYUpdated Sep 22, 2026Quarterly Revenue Growth
19.10%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
199.88MCNY29.84M · vs all stocks (USD)
EBITDA (TTM)
94.54MCNY14.11M · vs all stocks (USD)
Net Income (TTM)
42.53MCNY6.35M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-84.10%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
20.38MCNY3.04M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-23.68MCNY-3.53M · vs all stocks (USD)
Forward Annual Dividend Rate
0.2500CNYUpdated Sep 22, 2026Forward Annual Dividend Yield
1.62%vs all stocks
Trailing Annual Dividend Rate
0.2500CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
1.67%vs all stocks
5-Year Average Dividend Yield
2.06%vs all stocks
Payout Ratio
96.15%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
12.96MCNYFY2025 · Dec 31, 2025Revenue
447.42MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
247.58MCNYFY2025 · Dec 31, 2025Gross Profit
199.84MCNYFY2025 · Dec 31, 2025Operating Income
55.89MCNY8.34M · vs all stocks (USD)
Pre-tax Income
60.94MCNYFY2025 · Dec 31, 2025Income Tax Expense
16.37MCNYFY2025 · Dec 31, 2025Net Income
44.57MCNYFY2025 · Dec 31, 2025EBIT
62.54MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
94.54MCNYFY2025 · Dec 31, 2025Research & Development
47.20MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
42.97MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.97MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.92MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.60MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4000CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
162.35MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
162.35MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
44.57MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
20.37MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
83.07MCNYFY2025 · Dec 31, 2025Free Cash Flow
29.26MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
227.23MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
44.57MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.78MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
55.12MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.40MCNYFY2025 · Dec 31, 2025Capital Expenditures
-53.81MCNYFY2025 · Dec 31, 2025Purchase of Investments
-942.00MCNYFY2025 · Dec 31, 2025Sale of Investments
945.17MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-50.64MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
21.02MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-70.00KCNYFY2025 · Dec 31, 2025Common Dividends Paid
-1.27MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.23MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
18.45MCNYFY2025 · Dec 31, 2025Shares Outstanding
164.32MSharesUpdated Sep 22, 2026Float Shares
48.34MSharesUpdated Sep 22, 2026% Held by Insiders
68.57%vs all stocks
% Held by Institutions
5.95%vs all stocks
Total Cash (MRQ)
253.88MCNY37.90M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.57CNYUpdated Sep 22, 2026Total Debt (MRQ)
64.33MCNY9.60M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0834xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.52xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
4.80CNYUpdated Sep 22, 2026Total Assets
1.19BCNY176.95M · vs all stocks (USD)
Total Current Assets
709.31MCNYFY2025 · Dec 31, 2025Total Liabilities
310.41MCNYFY2025 · Dec 31, 2025Total Non-current Assets
476.14MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
72.19MCNYFY2025 · Dec 31, 2025Total Current Liabilities
238.22MCNYFY2025 · Dec 31, 2025Cash
231.11MCNYFY2025 · Dec 31, 2025Cash Equivalents
3.31MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
234.42MCNYFY2025 · Dec 31, 2025Other Short-term Investments
151.55MCNYFY2025 · Dec 31, 2025Accounts Receivable
91.19MCNYFY2025 · Dec 31, 2025Inventory
163.62MCNYFY2025 · Dec 31, 2025Accounts Payable
56.61MCNYFY2025 · Dec 31, 2025Short-term Debt
6.82MCNYFY2025 · Dec 31, 2025Other Current Liabilities
6.57MCNYFY2025 · Dec 31, 2025Long-term Debt
56.00MCNYFY2025 · Dec 31, 2025Common Stock (Book)
166.22MCNYFY2025 · Dec 31, 2025Retained Earnings
206.08MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
875.04MCNY130.62M · vs all stocks (USD)
Treasury Stock
29.17MCNYFY2025 · Dec 31, 202552-Week Low
11.66CNYUpdated Sep 22, 202652-Week High
21.70CNYUpdated Sep 22, 202652-Week Change
-19.27%vs all stocks
Beta
0.6920xvs all stocks
50-Day MA
14.41CNYUpdated Sep 22, 2026200-Day MA
15.94CNYUpdated Sep 22, 2026Avg 10-Day Volume
1.51MSharesUpdated Sep 22, 2026Avg 30-Day Volume
1.91MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.2600CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 6,349,000.622Operating Cash Flow (USD, TTM): 3,042,341.131
Financial Health
Altman Z-Score 6.32: safe zoneNotable
Altman Z-Score: 6.32
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shenzhen V&T Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Grupo Rotoplas, S.A.B. de C.V.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Cub Elecparts Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangdong Songyang Recycle Resources Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
RDC Semiconductor Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Jiangsu Newamstar Packaging Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Zhejiang Baida Precision Manufacturing Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Suzhou Industrial Park Heshan Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Bajaj Electricals Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ege Profil ve Sanayi A.S.
Tier 1ProductionThroughput-Bound ConversionFlowRule